Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-15

Clinical Trial Update: Alzheimer's Disease Reminiscence Quality of Life [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating reminiscence-based quality of life in Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universidad Nacional de Rosario | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED